Overview

Prostate cancer is one of the most common cancers affecting men. Many prostate cancers are detected early through PSA screening and routine evaluation, allowing patients to benefit from a wide range of treatment options.

While surgery, radiation therapy, hormone therapy, and active surveillance remain the most common treatment approaches, some patients may benefit from image-guided therapies as part of a comprehensive cancer care plan.

ELMNT IR works closely with urologists, oncologists, radiation oncologists, and referring physicians to provide minimally invasive treatment options that complement traditional cancer care.

Symptoms of Prostate Cancer

Early prostate cancer often causes no symptoms, and many cases are identified before symptoms develop. When symptoms do occur, they may include:
Urinary Changes: Difficulty urinating, a weak urinary stream, or frequent urination.
Physical Findings: Blood in the urine or blood in semen.
Pain & Discomfort: Pelvic discomfort, or bone pain in advanced disease.

When to Seek Treatment

Not every prostate cancer requires immediate treatment, but all diagnosed patients should undergo appropriate evaluation and treatment planning. Treatment decisions should be carefully guided by:
Cancer stage and PSA levels.
Specific tumor characteristics.
Patient’s age and overall health.
Personal treatment preferences.

How Prostate Cancer is Diagnosed

Before determining the most effective treatment pathway, a comprehensive diagnosis typically involves:
Screening & Exams: PSA testing and a physical examination.
Advanced Imaging: High-resolution MRI imaging, and PET imaging in select cases.
Pathology: Tissue biopsy.
Expert Collaboration: Detailed consultation with urology and oncology specialists.

ELMNT IR collaborates with referring physicians to support multidisciplinary treatment planning when image-guided therapies may be beneficial.

Treatment Options

Depending on the specific disease stage and characteristics, treatment may include:
Active surveillance.
Surgical options.
Radiation therapy or hormone therapy.
Chemotherapy or immunotherapy.
Interventional oncology procedures.

A Targeted Treatment Approach

Interventional oncology therapies can provide targeted treatment options for select patients with prostate cancer, metastatic disease, or treatment-related complications. These image-guided procedures are designed to complement traditional therapies and support a comprehensive cancer care plan.

👉 Learn more about Interventional Oncology Procedures

Interventional Oncology at ELMNT IR

Interventional oncology focuses on highly targeted therapies delivered through advanced imaging guidance. These procedures can help address cancer directly while minimizing disruption to surrounding healthy tissue, often serving as a key component of a broader multidisciplinary treatment strategy.

Who is a Candidate?

You may be an ideal candidate for image-guided treatment if:
Disease Profile: You have prostate cancer requiring additional localized treatment.
Metastatic Focus: You have metastatic disease that requires a targeted intervention.
Surgical Risk: Traditional treatment options are not ideal or preferred for your situation.
Clinical Support: Your core oncology team formally recommends a minimally invasive approach.

⚠️ A professional consultation and comprehensive imaging review are required to determine final candidacy.

Why Choose ELMNT IR?

Advanced Expertise: Specialized expertise in state-of-the-art image-guided oncology procedures.
Collaborative Care: Close and continuous coordination with urologists and oncology teams.
Targeted Therapies: Mastery of advanced embolization and tumor-directed therapies.
Patient Comfort: An outpatient-focused environment designed for maximum comfort, safety, and efficiency.

Next Steps

If you have been diagnosed with prostate cancer, an evaluation can help determine whether image-guided treatment options are the right fit as part of your overall treatment plan.

📩 Request a Consultation or speak with your physician about a referral to ELMNT IR.